Supplemental data for the manuscript: Long-term safety of growth hormone in adults with growth hormone deficiency: Overview of 15,809 GH-treated patients

Gudmundur Johannsson; Philippe Touraine; Ulla Feldt-Rasmussen; Antonio Pico; Greisa Vila; Anders F Mattsson; Martin Carlsson; Márta Korbonits; André P. van Beek; Michael Wajnrajch; Roy Gomez; Kevin Yuen

doi:10.25454/pfizer.figshare.16595993

Dataset

Supplemental data for the manuscript: Long-term safety of growth hormone in adults with growth hormone deficiency: Overview of 15,809 GH-treated patients

Gudmundur Johannsson, Philippe Touraine, Ulla Feldt-Rasmussen, Antonio Pico, Greisa Vila, Anders F Mattsson, Martin Carlsson, Márta Korbonits, André P. van Beek, Michael Wajnrajch, …

Pfizer

09/14/2021

DOI: https://doi.org/10.25454/pfizer.figshare.16595993

Abstract

Endocrinology

FOS: Clinical medicine

This dataset contains data about GH dose effects on AEs in KIMS, and effects of GH replacement on lipid profiles and glucose metabolism from major clinical practice studies in adults with GHD.

Files and links (1)

url

https://doi.org/10.25454/pfizer.figshare.16595993View

Open

Metrics

1 Record Views

Details

Title: Supplemental data for the manuscript: Long-term safety of growth hormone in adults with growth hormone deficiency: Overview of 15,809 GH-treated patients
Creators: Gudmundur Johannsson
Philippe Touraine
Ulla Feldt-Rasmussen
Antonio Pico
Greisa Vila
Anders F Mattsson
Martin Carlsson
Márta Korbonits
André P. van Beek
Michael Wajnrajch
Roy Gomez
Kevin Yuen
Publisher: Pfizer
Identifiers: 991006262192402656
Academic Unit: Internal Medicine
Language: English
Resource Type: Dataset